Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReproGen is a South Korean biotechnology company specializing in molecular diagnostics and genetic testing, with a primary focus on reproductive health and prenatal care. The company provides a comprehensive suite of services including Non-Invasive Prenatal Testing (NIPT), Preimplantation Genetic Screening (PGS), and Preimplantation Genetic Diagnosis (PGD) to identify chromosomal abnormalities and genetic disorders. ReproGen leverages advanced genomic sequencing and bioinformatics to deliver high-accuracy diagnostic solutions for clinical and research applications. By integrating cutting-edge molecular biology with clinical diagnostics, the company aims to improve pregnancy outcomes and support personalized reproductive medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reprogen.